Evidence map›Paper›PMID 40821300›Full record

ArticleCureus2025

Metastatic Lung Adenocarcinoma in a Lifetime Nonsmoker With an Atypical Radiological and Clinical Presentation.

Yan Naing Tun, Fizza Mohsin, Muhammad H Khan, Shaurya Sharma, Ravikaran Patti

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan Naing TunInternal Medicine, Maimonides Medical Center, Brooklyn, USA.
Fizza MohsinInternal Medicine, Maimonides Medical Center, Brooklyn, USA.
Muhammad H KhanInternal Medicine, Maimonides Medical Center, Brooklyn, USA.
Shaurya SharmaInternal Medicine, Maimonides Medical Center, Brooklyn, USA.
Ravikaran PattiPulmonary and Critical Care Medicine, Maimonides Medical Center, Brooklyn, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains the leading cause of cancer-related deaths globally. While smoking-related lung cancers still account for most cases and cause approximately 100,000 deaths annually in the USA, smoking rates have been declining for decades. Lung cancer in never-smokers (LCINS), which tends to affect women and Asian populations, is now the fifth most common cause of cancer-related deaths worldwide. In 2023, over 20,000 lung cancer deaths in the USA were projected to occur in never-smokers, making LCINS the eighth leading cause of cancer-related mortality in the country. As the number of LCINS cases rises, it becomes increasingly important to explore the unique causes and characteristics of the disease, which calls for tailored diagnostic approaches and personalized treatment plans. Lung adenocarcinoma (LUAD) can present with atypical imaging features that often resemble benign conditions, including pneumonia, lung abscesses, post-infectious scarring, atelectasis, mediastinal masses, emphysema, and granulomatous disease. This variability in presentation can hinder accurate diagnosis and potentially delay timely treatment. While lung cancer is uncommon in younger individuals, with only 5.6% of new cases occurring in those under 54 years old, clinicians should maintain a high index of suspicion, as early detection is essential, and atypical cases can be easily missed. Here, we present a complex case involving an unusual radiologic manifestation of a lung mass, in which tuberculosis was initially considered the primary differential diagnosis.

Indexed as

adenocarcinoma of the lungatypical presentationearly detection of cancernon-smokingpulmonary nodule characterization

Identifiers

PMID40821300
PMCPMC12350203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.